跳至主要内容
临床试验/NCT07675161
NCT07675161已完成不适用

CIP361: MiniMed Fit Payload Wear Pediatric Study

Medtronic MiniMed, Inc.10 个研究点 分布在 1 个国家目标入组 59 人开始时间: 2026年6月25日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
59
试验地点
10
主要终点
Summary of device survival

研究概览

简要总结

The purpose of this study is to assess MiniMed Fit Payload adhesive components in different wear locations over a 7-day period to support development of the future commercialized patch pump in participants 7-17 years of age.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
7 Years 至 17 Years(Child)
性别
All
接受健康志愿者

入选标准

  • Participants with insulin-requiring diabetes
  • Participants 7-17 years of age
  • Participant and parent/guardian/legally authorized representative are able and willing to sign informed consent/assent

排除标准

  • Participants who report known skin sensitivity or allergy to polycarbonate or pressure-sensitive adhesives, e.g., medical device adhesives, band-aids, other acrylic-containing adhesives.
  • Participants with any skin condition in the area where device placement (e.g., irritation, rash, infection) could occur, per participant report.
  • Participants who are pregnant (per self-report) at initial screening. If a participant becomes pregnant during the study, the site will follow procedures for study withdrawal.

研究组 & 干预措施

MiniMed Fit Payload adhesive components

Pediatric participants with insulin-requiring diabetes using the MiniMed Fit Payload adhesive components in different wear locations over a 7-day period.

干预措施: MiniMed Fit Payload adhesive components (Device)

结局指标

主要结局

Summary of device survival

时间窗: 7 Days

The number of MiniMed Fit Payload that remain securely attached to the skin at the end of day 7. This is a descriptive endpoint.

次要结局

未报告次要终点

研究者

发起方
Medtronic MiniMed, Inc.
申办方类型
Industry
责任方
Sponsor

研究点 (10)

Loading locations...

相似试验